Read the latest edition of Australian Diabetes Research Review Diabetes_Research_Review_Issue_113
This edition features:
– Dual SGLT-1/2 inhibition with sotagliflozin in T1DM
– Adding semaglutide vs. sitagliptin in T2DM uncontrolled with metformin/sulfonylurea
– Long-term weight loss with metformin or lifestyle intervention
– Dapagliflozin ±saxagliptin in T2DM and CKD
– Data-driven subgroups versus clinical feature models for T2DM progression/response
– Suspend-before-low insulin pump technology in hypoglycaemia-prone T1DM
– Primary care-led weight-management intervention for T2DM
– Semaglutide added to SGLT-2 inhibitor in T2DM
– Structured SMBG ±TeleCare support in non-insulin treated T2DM
– Physical exercise and intermittently viewed CGM performance in T1DM